Jay Shetty and his health advice are everywhere

The wellness influencer and former monk knows how to get attention and prop up his own interests.

October 10, 2025 Check out STAT+

Sponsored By

A big congratulations to STAT's Lev Facher, who last night won a Loeb Award, the highest honor in business and financial journalism, in explanatory reporting for his series "The War on Recovery."

Photo illustration: Alex Hogan/STAT; Photo: Getty Images Jay Shetty and his health advice are everywhere. It's by design The author, entrepreneur, and host of the health podcast "On Purpose" helps people overcome issues from their past. His own past is a different story. By Alexa Lee STAT+ | HHS employees to be fired as White House enacts mass terminations it blames on shutdown It's not yet clear how many workers would be let go as part of the reduction in force, which the White House has blamed on the shutdown. By Chelsea Cirruzzo STAT+ | AstraZeneca set to strike drug pricing deal with Trump More details of the agreement between Trump and U.K.-based AstraZeneca are set to be shared at the White House this evening. By Daniel Payne Courtesy Emily Portugal Opinion: My mother had Alzheimer's. I watched her slip away in the fragile care system My mother's treatment at a continuing care community was a casualty in the math of profit over people. By Emily Portugal STAT+ | Senate-passed BIOSECURE Act would add arrow to Trump's drug-pricing quiver The legislation would restrict U.S. pharmaceutical and biotechnology companies from doing business with certain Chinese companies. By John Wilkerson STAT+ | Bristol Myers to buy startup Orbital Therapeutics, building out cell therapy pipeline Orbital has been developing in vivo CAR-T treatments that could make it easier to use cell therapies to treat autoimmune disorders. By Jason Mast AP Opinion: RFK Jr. says vaccines don't save lives. He's wrong Health secretary Robert F. Kennedy Jr. says nutrition and sanitation, not vaccines, stopped polio and measles. Here's the truth. By Ezekiel J. Emanuel, Abe Baker-Butler, and Michael T. Osterholm STAT+ | Roche suffers setback as court allows generic version of its rare disease drug to be sold in India Roche has sought to prevent a generics company from proceeding with plans to make a version of a spinal muscular atrophy therapy. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser